POROCARCINOMA

Clinical trials for POROCARCINOMA explained in plain language.

Never miss a new study

Get alerted when new POROCARCINOMA trials appear

Sign up with your email to follow new studies for POROCARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

Virus and immunotherapy combo shows promise for Tough-to-Treat skin cancers

Disease control Ongoing

This study is testing a two-step treatment for people with rare skin cancers or certain lymphomas that have not responded to standard therapies. First, patients receive a virus-based drug (talimogene laherparepvec) injected directly into tumors. Then, they also get an immunothera…

Matched conditions: POROCARCINOMA

Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control

Last updated Jun 15, 2026 18:55 UTC

POROCARCINOMA

Get alerted when new POROCARCINOMA trials appear

Virus and immunotherapy combo shows promise for Tough-to-Treat skin cancers